A carregar...
Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas
Despite substantially improved survival with rituximab-based treatment regimens, there is an unmet medical need for better treatments of B-cell lymphoma, particularly for patients with relapsed or refractory disease. Retreatment with rituximab exerts a limited effect in these patients, and platinum-...
Na minha lista:
| Publicado no: | Blood Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8093997/ https://ncbi.nlm.nih.gov/pubmed/33935029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2021.2020320 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|